RFK Jr. set to ban common food dyes from food supply including colorings for M&Ms, Lucky Charms and Gatorade
Health and Human Services Secretary Robert F. Kennedy, Jr., is expected to announce the Food and Drug Administration's intent to phase out the use of petroleum-based synthetic dyes in the nation's food supply - and its coloring used in many common foods.
The Trump administration says the move could mark a 'major step forward' in the drive to 'Make America Healthy Again.' The ban would impact products such as breakfast cereals, candy and snacks. They dyes been tied to neurological problems in some children.
'We've shown now that this directly affects academic performance, violence in the schools, and mental health, as well as physical health,' Kennedy said at a cabinet meeting earlier this month.
It is unclear when the changes could be implemented, but Kennedy is slated to give more details later Tuesday.
The secretary is anticipated to announce the approval of additional natural dyes, a person familiar with the plans told ABC News.
Here are the dyes that could be up on the chopping block and what they're commonly found in:
Red No. 40 – Pepsi Blue, Starburst and medication NyQuil.
Citrus Red No. 2 – Used to color the skin of some oranges
Yellow No. 6 – Airheads and cosmetic products including Bobbi Brown and MAC lipstick.
Yellow No. 5 – Mountain Dew and Doritos
Blue No. 1 – Blue Takis chips and MAC eyeshadow
Blue No. 2 – Oxycodone and a common bakery McCormick food dye.
Green No. 3 – Advil Liquid-gels
Recent research shows synthetic food colors found in U.S. foods are linked to neurobehavioral problems in children and that the dyes may cause or exacerbate symptoms, particularly hyperactivity. In addition, children may vary widely in their sensitivity to the dyes.
'It is clear that some children are likely to be more adversely affected by food dyes than others,' the California's Office of Environmental Health Hazard Assessment reported in 2021.
Nevertheless, there is no clear evidence of a direct relationship between food dyes, academic performance, violence or other mental and physical conditions, scientists say.
Scientific evidence shows that 'most children have no adverse effects when consuming foods containing color additives,' according to the FDA.
The FDA banned the dye known as Red 3 from the nation's food supply in January. It said the dye, also known as erythrosine, caused cancer in lab rats. A federal law requires the administration to ban any additive found to cause cancer in animals. However, officials stressed that the way Red 3 leads to cancer in rats doesn't happen in people.
Dr. Peter Lurie, a former FDA official, told the BBC that the only purpose of the artificial food dyes is to "make food companies money.'
"Food dyes help make ultra-processed foods more attractive, especially to children, often by masking the absence of a colorful ingredient, like fruit," he said. "We don't need synthetic dyes in the food supply, and no one will be harmed by their absence."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Reuters
2 hours ago
- Reuters
Teens turn to weight loss drugs in fight against childhood obesity
Roughly 8 million American teens are living with obesity - that's one in five. For many, their weight has become a painful physical and emotional burden, isolating them from their peers as they struggle to slim down. But now there is another option: weight-loss drugs. Reuters reporters spent more than a year closely following four teenagers who joined a small but fast-growing cohort choosing to take this medication. This video contains content some people may find distressing. Lauren Roback reports.
The Independent
3 hours ago
- The Independent
US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need
US medicines regulator the Food and Drug Administration (FDA) has approved a groundbreaking HIV prevention jab hailed as having the potential to quell the Aids pandemic. But the moment has been overshadowed by the spectre of aid cuts, placing in doubt whether this breakthrough injection – lenacapavir – will get to the people who need it most. Lenacapavir given in a twice-yearly injection stops HIV from replicating, protecting close to 100 per cent of people from developing the virus if they are exposed to it. This approval is one of the last crucial steps to getting the drug, branded Yeztugo, out to patients. Although the FDA's approval only applies to US patients, the World Health Organization (WHO) said it paved the way for its own recommendation of the drug and for approval in other countries. Director of WHO's Global HIV, Hepatitis and STI Programmes, Dr Meg Doherty described it as a 'regulatory milestone' adding: 'We are working with partners and national authorities to ensure lenacapavir reaches people who need it most – quickly, safely and equitably.' Researchers have raised concerns that, amid aid cuts, the jab will be too expensive to be taken up by lower-income countries. Gilead – the drugs company producing lencapavir – did not make public the cost of each dose to global funders but it announced a US price of $28,218 per year for each patient. 'If this game-changing medicine remains unaffordable, it will change nothing,' said Winnie Byanyima, executive director of the United Nations' Aids agency, UNAIDS. She called the approval of lenacapavir a 'breakthrough moment' adding the jab, 'could be the tool we need to bring new infections under control – but only if it is priced affordably and made available to everyone who could benefit. ' UNAIDS has seen research that lenacapavir can be produced for just $40 per person per year, falling to $25 within a year of roll out. It is beyond comprehension how Gilead can justify a price of $28,218.' Dr Andrew Hill, a pharmacology research fellow at the University of Liverpool, worked on the research which found lenacapavir could be provided for as little as $25, including a 30 per cent profit margin. 'Scientifically, it's a great moment that we have a drug which has been judged to be safe and efficacious by a leading regulatory authority in the world,'' he said. 'Public health-wise and in terms of the epidemic, it's tragic because the drug is so expensive that it's not going to get used'. It is also unlikely to be affordable in the UK, he said, despite government promises to end new cases of HIV in England by 2030. A Gilead spokesperson said, 'Yeztugo is priced in line with existing branded PrEP [pre-exposure prophylaxis] options. We are working to make Yeztugo accessible for anyone who needs or wants it and expect to see broad insurance coverage in the US. 'We're taking unprecedented actions with urgency to plan for access to lenacapavir for PrEP globally—particularly in low- and lower-middle-income countries where the need is greatest.' Gilead signed agreements with six pharmaceutical companies in India, Pakistan, Egypt, and the US to allow them to make generic versions of the drug in order to increase supply and drive down the cost of the jab. This will take some time. Gilead also agreed to sell enough doses of the jab to protect at least two million people over three years in lower-income countries. These would be paid for by global funders led by the US President's Emergency Plan for Aids Relief (Pepfar) and the Global Fund to Fight Aids, Tuberculosis and Malaria. However, The Independent reported earlier in the month that these doses are now at risk because of US funding cuts. A significant chunk of the money to fund the doses of lenacapavir was set to come from the US-led global Aids response programme, Pepfar, as well as the Global Fund whose biggest donor was the US. This funding is now uncertain. Figures previously reported by The Independent suggest President Trump's slashing of foreign aid has derailed the projected end of the Aids pandemic and could lead to four million extra deaths by 2030. 'It does feel like this thing that could help us end the epidemic sooner is suddenly receding in the chaos,' said Prof Linda-Gail Bekker, whose trial demonstrated lenacapavir's effectiveness. The aid-funded doses are thought to cost much less than the US list price of almost $30k but still roughly five times more expensive than Dr Hill believes is necessary. And they are in an initial pilot phase, he said: 'We need to get into a different level where we're giving lenacapavir to tens of millions of people'. This is even more important as aid cuts are slashing the HIV prevention budgets of governments across Africa, he said. 'We're in this crazy position where we have a brand new highly effective vaccine-like drug and actually we will probably see the epidemic get worse over the next four years.'
The Guardian
5 hours ago
- The Guardian
Pandemic preparedness ‘dramatically eroding' under Trump, experts say
Amid controversial dismissals for independent advisers and staff at health agencies, alongside lackluster responses to the bird flu and measles outbreaks, experts fear the US is now in worse shape to respond to a pandemic than before 2020. H5N1, which has received less attention under the Trump administration than from Biden's team, is not the only influenza virus or even the only variant of bird flu with the potential to spark a pandemic. But a subpar response to the ongoing US outbreak signals a larger issue: America is not ready for whatever pathogen will sweep through next. 'We have not even remotely maintained the level of pandemic preparedness – which needed a lot of work, as we saw from the Covid pandemic,' said Angela Rasmussen, an American virologist at the Vaccine and Infectious Disease Organization at the University of Saskatchewan in Canada. 'But now, we essentially have no pandemic preparedness.' 'I'm concerned on a number of fronts,' said Jennifer Nuzzo, professor of epidemiology and director of the Pandemic Center at Brown University School of Public Health. Those concerns include a lack of quality information from officials, weakened virus monitoring systems, and public health reductions at the federal, state and local levels. 'The thing that I am most concerned about is the veracity of information coming out of the health agencies,' Nuzzo said. In the ongoing outbreaks of measles, for example, Robert F Kennedy Jr, the secretary of health and human services, has downplayed the severity of the disease, spread misinformation about the highly effective vaccine to prevent measles, and pushed unproven treatments. 'The communications on measles gives me deep worries about what would happen in a pandemic,' Nuzzo said. 'If a pandemic were to occur today, the only thing we would have to protect ourselves on day one would be information.' The H5N1 outbreak has been plagued by incomplete information, an issue that began in the Biden administration but has amplified under Trump. In Arizona, 6 million chickens were killed or culled at a Hickman's Family Farms location because of H5N1 in May. That's about 95% of the company's hen population in the state. Hundreds of workers, including inmate laborers, are now being dismissed as Arizona braces for egg shortages. Yet even as H5N1 outbreaks continue to spread on farms and wreak havoc on the food supply, no new bird flu cases have been reported in people for months. 'I am concerned that we may not be finding new infections in humans,' Nuzzo said – and a lack of testing may be the culprit. 'We're not testing – it's not that there are no new cases,' Rassmussen said. The last bird flu case in a person was listed by the US Centers for Disease Control and Prevention (CDC) on 23 February. At that point, at least 830 people in the US had been tested after contact with sick animals. This kind of testing – monitoring the health of people who regularly work with H5N1-infected animals – is how the vast majority of cases (64 out of 70) have been found in this outbreak. But then, several CDC officials overseeing the bird flu response were fired on 1 April. Since then, only about 50 people in the US have been tested after exposure to sick animals – and no positive cases have been announced. It's also been difficult to understand the extent of the outbreak and how the virus spreads among animals. 'We still just don't have a good picture of the scope and scale of this outbreak – we never really have. And until we have that, we're not going to be able to contain it,' Rasmussen said. 'It's extremely bad,' she continued. 'We don't have any information about what's happening right now. The next pandemic could be starting, and we just don't know where that's happening, and we don't have any ability to find out.' Huge reductions in the public health workforce and resources has led to less monitoring of outbreaks, known as disease surveillance. 'Cutting back on that surveillance is leaving us more in the dark,' Nuzzo said. The CDC clawed back $11.4bn in Covid funding in March. This funding was used to monitor, test, vaccinate and otherwise respond to public health issues at the state, local, territorial and tribal level. 'We're seeing health departments scrambling,' Nuzzo said. 'That infrastructure is just dramatically eroding.' International monitoring programs to address outbreaks before they expand across borders have also been cancelled. 'We have taken for granted all of those protections, and I fear that we are poised to see the consequences,' Nuzzo said. Trump's crackdown on immigration also poses a major challenge in detecting cases and treating patients during outbreaks. 'A lot of the people who are most at risk are strongly disincentivized to report any cases, given that many of them are undocumented or are not US citizens,' Rasmussen said. 'Nobody wants to go get tested if they're going to end up in an Ice detention facility.' When cases are not detected, that means patients are not able to access care. Although it's rare for people to become sick with H5N1, for instance – the virus is still primarily an avian, not a human, influenza – this variant of bird flu has a 52% mortality rate globally among people with known infections. Allowing a deadly virus to spread and mutate under the radar has troubling implications for its ability to change into a human influenza without anyone knowing. And if such changes were detected, widening gaps in communication could be the next hurdle for preventing a pandemic, Nuzzo said. 'Communication is our most important public health intervention. People, in order to be able to know how to protect themselves, need to have access to facts, and they need to believe in the messengers. And the communication around the measles outbreaks are deeply eroding our standing with the American people.' Even stockpiled vaccines and other protective measures, like personal protective equipment, take time to distribute, Nuzzo added. 'And flu is a fast-moving disease that could cause a lot of damage in the months it would take to mount a vaccination campaign.' The US government's cancellation of its $766m contract with Moderna to research and develop an H5N1 vaccine also signals a concerning strategy from health officials, Nuzzo and Rasmussen said. Other restrictions on vaccine development, like a new plan to test all vaccines against saline placebos, is 'going to make it extremely difficult to approve any new vaccine' and would 'have a devastating impact on our ability to respond to a potential pandemic', Rasmussen said – especially in a rapidly moving pandemic where speed matters. 'You don't have time for that if this virus causes a human-to–human outbreak,' Rasmussen said. All of these policies mean the US is less prepared for a pandemic than it was in 2020, she said. And it also means there will be preventable suffering now, even before the next big one strikes. 'We are actively making people less safe, less healthy and more dead,' Rasmussen said.
